liu lei
Professor
刘磊，男，1981年生，教授、博士生导师，学院副院长 入选国家杰青、国家优青、泰山学者特聘专家、教育部新世纪优秀人才、山东省杰青、山东大学齐鲁青年学者 学术任职：任 中国化学会有机化学学科委员会委员（2022-）、 Chin. Chem. Lett.编委（2021-）、《有机化学》青年编委（2019-） 研究方向：仿生不对称氧化、复杂分子不对称合成、抗菌金属药物化学生物学 邮箱：leiliu@sdu.edu.cn 地址：山东省济南市历城区山大南路27号山东大学老数学楼113 课题组英文主页：http://leiliugro... More+
Scientific Research
Working-Papers
- No content
Paper Publications
More>-
Du, Tianxing. Copper-Catalyzed [3 + 2 + 1] Cycloaddition of Alkenes with Benzoquinones and Dicarbonyl Compounds via Tandem Oxidative Dicarbofunctionalization/Cyclization Sequence. Chinese Journal of Chemistry, 40, 1681-1686, 2023.
-
秦静. Design, synthesis and biological evaluation of novel 1,3,4,9-tetrahydropyrano[3,4-b]indoles as potential treatment of triple negative breast cancer by suppressing PI3K/AKT/mTOR pathway. Bioorg Med Chem., 55, 116594, 2023.
-
. Redox deracemization of β,γ-alkynyl α-amino esters. 2041-6520, 11, 4444-4449, 2023.
-
王东琳. 叔丁醇钠催化的δ-腈基-δ-芳基-双取代的对亚甲基苯醌和二芳基氧磷的磷氢化反应研究. Chinese journal of organic chemistry, 41, 3192-3203, 2023.
-
叶鹏博. Nickel(II)-catalyzed asymmetric alkylation of acyclic oxocarbenium ions with carboxylic acid derivatives. CHINESE CHEMICAL LETTERS Journal, 32, 1237, 2023.
-
. Site- and Enantiodifferentiating C(sp3)？H Oxidation Enables Asymmetric Access to Structurally and Stereochemically Diverse Saturated Cyclic Ethers. journal of the american chemical society, 2023.
-
秦静. Design, synthesis and biological evaluation of novel 1,3,4,9-tetrahydropyrano[3,4-b]indoles as potential treatment of triple negative breast cancer by suppressing PI3K/AKT/mTOR pathway. BIOORGANIC & MEDICINAL CHEMISTRY Journal, 55, 2022.
-
杜天星. Copper-Catalyzed [3？+？2？+？1] Cycloaddition of Alkenes with Benzoquinones and Dicarbonyl Compounds via Tandem Oxidative Dicarbofunctionalization/Cyclization Sequence. Chinese Journal of Chemistry, 2022.
Patents
- No content
Published Books
- No content
Research Projects
More>-
手性有机叠氮标准品的合成, 2023-12-14-2024-12-31
-
系列糖类高级衍生物的制备和在生物医药领域的应用, 2023-12-04-2024-12-31
-
抗肿瘤药物芦可替尼手性合成工艺研发, 2021-10-10-2026-10-09
-
（包干项目）新型1,3,4，9-四氢吡喃[3,4-b]_吲哚类化合物基于PI3K/AKT/mTOR信号通路抗三阴性乳腺癌的作用及机制, 2022-01-01-2024-12-31
-
H045 项目片段 2 委托工艺开发（L）, 2022-03-25-2027-03-24
-
手性[N4]铁催化不对称脱氢反应, 2021-12-20-2024-09-30
-
氮、磷、硅等杂原子手性中心的不对称氧化构筑, 2021-12-03-2024-12-31
-
烯烃的不对称环氧化, 2021-10-01-2026-10-01
Research Team
- No content